SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-265158
Filing Date
2023-10-27
Accepted
2023-10-27 16:23:01
Documents
17
Period of Report
2023-10-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d560299d8k.htm   iXBRL 8-K 29532
2 EX-1.1 d560299dex11.htm EX-1.1 273408
3 EX-4.1 d560299dex41.htm EX-4.1 63585
4 EX-5.1 d560299dex51.htm EX-5.1 18097
8 GRAPHIC g560299g03j29.jpg GRAPHIC 9110
9 GRAPHIC g560299g52a25.jpg GRAPHIC 15197
  Complete submission text file 0001193125-23-265158.txt   646790

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA idya-20231024.xsd EX-101.SCH 2857
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20231024_lab.xml EX-101.LAB 18738
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20231024_pre.xml EX-101.PRE 11712
11 EXTRACTED XBRL INSTANCE DOCUMENT d560299d8k_htm.xml XML 3482
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38915 | Film No.: 231355872
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences